C-type natriuretic peptide: a potential marker of chronic kidney disease in diabetes
There is an urgent need for an early test for diabetic kidney disease enabling beneficial interventions before irreversible kidney damage occurs. read more
In the future, (interstitial) glucose monitoring technology might allow patients to have a small sensor inserted in their arm at clinic, then return the sensor by courier-post after two weeks of wear. This study will assess whether this technology can be used to diagnose diabetes, in patients with chronic liver disease.
Associate Professor Lunt is currently a Diabetes Physician at the Christchurch Diabetes Centre, a Clinical Director of the Health Innovation Hub at the Canterbury District Health Board, and a Clinical Associate Professor at the University of Otago, Christchurch.
More About Associate Professor Helen Lunt